Analysts Set Establishment Labs Holdings Inc. (NASDAQ:ESTA) PT at $79.60

Establishment Labs Holdings Inc. (NASDAQ:ESTA) has received an average recommendation of “Buy” from the six analysts that are covering the stock, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $74.67.

Several equities research analysts have issued reports on the stock. Mizuho lowered their price objective on shares of Establishment Labs from $80.00 to $50.00 and set a “buy” rating for the company in a research report on Wednesday. JPMorgan Chase & Co. started coverage on shares of Establishment Labs in a research report on Thursday, August 31st. They issued an “overweight” rating and a $75.00 price objective for the company. Stephens reaffirmed an “overweight” rating and issued a $89.00 price target on shares of Establishment Labs in a research report on Friday, July 21st. Finally, B. Riley lowered their price target on shares of Establishment Labs from $95.00 to $50.00 and set a “buy” rating for the company in a research report on Thursday.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. JW Asset Management LLC boosted its holdings in shares of Establishment Labs by 0.8% in the 1st quarter. JW Asset Management LLC now owns 3,142,485 shares of the company’s stock valued at $211,772,000 after buying an additional 25,000 shares in the last quarter. RTW Investments LP raised its position in Establishment Labs by 0.6% in the 1st quarter. RTW Investments LP now owns 2,389,138 shares of the company’s stock valued at $161,840,000 after purchasing an additional 15,000 shares during the last quarter. Nantahala Capital Management LLC raised its position in Establishment Labs by 1.2% in the 1st quarter. Nantahala Capital Management LLC now owns 2,149,201 shares of the company’s stock valued at $144,835,000 after purchasing an additional 25,965 shares during the last quarter. Brown Advisory Inc. raised its position in Establishment Labs by 0.8% in the 3rd quarter. Brown Advisory Inc. now owns 1,482,180 shares of the company’s stock valued at $72,731,000 after purchasing an additional 11,780 shares during the last quarter. Finally, Cowen AND Company LLC raised its position in Establishment Labs by 18.1% in the 3rd quarter. Cowen AND Company LLC now owns 1,141,172 shares of the company’s stock valued at $55,997,000 after purchasing an additional 175,000 shares during the last quarter. Hedge funds and other institutional investors own 78.56% of the company’s stock.

Establishment Labs Stock Performance

Establishment Labs stock opened at $21.68 on Thursday. Establishment Labs has a twelve month low of $16.96 and a twelve month high of $79.88. The company has a quick ratio of 3.53, a current ratio of 3.71 and a debt-to-equity ratio of 6.08. The company’s 50-day moving average price is $41.73 and its 200-day moving average price is $57.19. The company has a market cap of $559.56 million, a PE ratio of -7.74 and a beta of 1.15.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.